Metabotropic Glutamate Receptors as Targets for Multipotential Treatment of Neurological Disorders
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 6 (1) , 94-107
- https://doi.org/10.1016/j.nurt.2008.10.038
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicityGlia, 2008
- Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformationPigment Cell & Melanoma Research, 2008
- NeuroprotectionArchives of Neurology, 2007
- Glutamate‐mediated neuronal–glial transmissionJournal of Anatomy, 2007
- mGluR1/5 subtype‐specific calcium signalling and induction of long‐term potentiation in rat hippocampal oriens/alveus interneuronesThe Journal of Physiology, 2006
- Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosisJournal of Neurochemistry, 2006
- Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptorsBritish Journal of Pharmacology, 2005
- Metabotropic glutamate receptors are expressed in adult human glial progenitor cellsBiochemical and Biophysical Research Communications, 2004
- Group III Metabotropic Glutamate Receptors in Rat Cultured Calvarial OsteoblastsBiochemical and Biophysical Research Communications, 2001
- Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of ratsNeuroscience Letters, 1995